Crossmark

A single-center outcome of choosing catheter ablation as the initial treatment in tachycardia–bradycardia syndrome and a new predictive factor for pacemaker implantation

Crossref DOI link: https://doi.org/10.1186/s42444-024-00126-5

Published Online: 2024-10-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kim, Hye Ree

Kim, Juwon

Kim, Ju Youn

Park, Seung-Jung

Park, Kyoung-Min

On, Young Keun
License Information

Text and Data Mining valid from 2024-10-02

Version of Record valid from 2024-10-02
More Information

Article History

Received: 15 November 2023

Accepted: 29 August 2024

First Online: 2 October 2024

Declarations

:

: This study protocol was approved by the Institutional Review Board at Samsung Medical Center, which waived the requirement of obtaining written informed consent from patients.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below